CDK12 and metastatic prostate carcinoma: KOURO_31-408, a case of metastatic prostate cancer with an aggressive course, showed a copy number plot similar to that previously reported as typical of CDK12 biallelic loss [4], and the small copy number gains might reflect focal tandem duplications (FTDs).